Press Release
BURLINGTON, Mass. (Sep 21, 2011) IntrinsiQ, a division of ION Solutions, today announces that its IntelliDose® version 3.9 has received the federal government’s “meaningful use” stamp of approval by earning EHR Modular certification. The designation officially deems the electronic health record (EHR) software or healthcare application capable of enabling providers to qualify for funding under the American Recovery and Reinvestment Act (ARRA). Tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB) program, the software is 2011/2012 compliant in accordance with the criteria adopted by the Secretary of Health and Human Services.
“With this certification, IntelliDose users can be confident our application is a key asset in helping them achieve their meaningful use targets,” said Andrew Scott, Director of Product Management for IntelliDose. IntelliDose is certified under number 09012011-1286-8 and listed on the ONC-Certified Health IT Product List.
Drummond Group’s ONC-ATCB 2011/2012 certification program tests and certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology – a key component of the federal government’s push to improve clinical care delivery through the adoption and effective use of EHRs by U.S. healthcare providers.
IntelliDose is the most trusted CPOE in medical oncology and is integrated with the leading clinical healthcare software suites, bringing oncology-specific functionality into EHRs and health information systems. By creating a unified system to track chemotherapy treatments, IntelliDose helps practices become safer and more efficient, reducing the margin for human error and allowing practitioners to spend less time entering data and more time with their patients. It’s widely installed at private and multi-specialty practices, community hospitals, and academic medical centers.
When used in conjunction with a certified EHR, IntelliDose will be a primary source of orders to help meet the requirements for CPOE as outlined in the meaningful use criteria. During Stage 1 of the ARRA program, the criteria for CPOE requires physicians to have entered ‘at least one medication’ electronically for at least 30% of their patients. For most practices currently using an EHR, this requirement can be easily met using the EMR alone. As healthcare moves to later stages of the ARRA program, the requirements will increase. IntelliDose will be used as a main source for CPOE in an oncology practice and was certified for this purpose. Using IntelliDose for CPOE will easily ensure that IntelliDose practices can maintain their success with this key requirement.
This modular EHR is 2011/2012 compliant and has been certified by Drummond Group, an ONC-ATCB approved to certify any complete or modular EHR both ambulatory and inpatient, in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. IntrinsiQ LLC’s IntelliDose version 3.9 was certified on 09/01/11 under certification number 09012011-1286-8.The certification criteria tested and certified were 170.302 A, D, E, O‐V and 170.304 A, C, E.
To see what IntelliDose can do for your oncology practice, request a demo at IntrinsiQ.com.
About IntrinsiQ
IntrinsiQ, a division of AmerisourceBergen Specialty Group’s ION Solutions unit, is the leading provider of medical oncology clinical information systems and the premier source of US oncology data and analysis. Each month, IntrinsiQ’s clinical software application, IntelliDose®, captures the treatment decisions and details from oncologists across the nation creating a database unrivaled in accuracy, detail and timeliness of information about the medical oncology care process. IntelliDose ensures patient safety though automation and standards designed to meet the needs of a specific practice, saving staff time, maximizing reimbursement and reducing operating costs. IntelliDose interfaces with leading EMR and hospital information systems, extending existing or planned technology investments to include cancer patient management. For more information, visit www.intrinsiq.com.
About Drummond Group
Drummond Group Inc., the trusted software test lab, provides effective and efficient electronic health record (EHR) testing to healthcare information technology vendors and hospitals. As an Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB), Drummond Group works closely with healthcare software vendors and hospitals to certify EHRs that are looking to qualify for incentive funds under the American Recovery and Reinvestment Act (ARRA). Drummond Group is approved to certify both complete and modular EHR for both ambulatory and inpatient. Leveraging more than a decade’s worth of interoperability, conformance testing and certification experience in multiple industries, Drummond Group delivers what’s needed in healthcare: highly reliable and readily affordable software testing services. For more information, go to www.drummondgroup.com.
About ION Solutions and AmerisourceBergen
A part of AmerisourceBergen Specialty Group, ION Solutions provides technologies, resources and expertise to community-based oncologists to help improve clinical and operational management. Information on ION Solutions can be found at www.iononline.com. AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to reimbursement and pharmaceutical consulting services. With $80 billion in annualized revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 10,000 people. AmerisourceBergen is ranked #27 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.